Aggressive lipid-lowering therapy after percutaneous coronary intervention-for whom and how?
Percutaneous coronary intervention (PCI) has been established as a definitive method to treat obstructive coronary artery disease. The procedure on its own, however, is insufficient to ensure optimal longterm patient outcomes as it is also necessary to achieve good control of relevant risk factors....
Saved in:
Main Authors: | Lee, Zhen-Vin, Lam, Ho |
---|---|
Format: | Article |
Published: |
Europa Group
2022
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/43936/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Young coronary artery disease in patients undergoing percutaneous coronary intervention
by: Zuhdi, A.S., et al.
Published: (2013) -
The impact of percutaneous coronary intervention (PCI) on diastolic dysfunction in coronary artery disease
by: Umar, Bello Tambuwal
Published: (2014) -
Enrollment and attendance to Cardiac Rehabilitation after Percutaneous Coronary Intervention in Sarawak : A Prospective Study
by: Chai, Li Sze, et al.
Published: (2019) -
Anxiety and depression among patients before and after Percutaneous Coronary Intervention (PCI) at National Heart Institute (NHI)
by: Ho, Siew Eng, et al.
Published: (2007) -
Transient cortical blindness after coronary angiography, bypass graft angiography, and coronary angioplasty
by: Lee, Zhen-Vin, et al.
Published: (2021)